Related Experiment Video

Updated: Apr 30, 2026

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients
12:23

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients

Published on: April 14, 2014

13.4K

Sustained disability improvement is associated with T1 lesion volume shrinkage in natalizumab-treated patients with

Luca Prosperini1, Floriana De Angelis1, Rosanna De Angelis1

  • 1Multiple Sclerosis Centre, S. Andrea Hospital, Rome, Italy Department of Neurology and Psychiatry, Sapienza University, Rome, Italy.

Journal of Neurology, Neurosurgery, and Psychiatry
|May 3, 2014
PubMed
Abstract

No abstract available in PubMed .

Keywords:
MRIMULTIPLE SCLEROSIS

More Related Videos

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

12.4K
Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin08:57

Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin

Published on: March 26, 2015

29.7K

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
20